1. Medtronic received FDA 510(k) clearance and breakthrough device designation for its LigaPass 2.0 ligament augmentation system.
2. The FDA gave an investigational device exemption to devicemaker 3Spine.
3. SeaSpine released its WaveForm C interbody system in a full commercial launch.
3. Medtronic named Lidia Fonseca as an independent director of its board of directors.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
